The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Management of Cocaine Abuse and Dependence
Abstract
During the 20th century, there have been recurrent episodes of cocaine abuse in the United States that have achieved epidemic proportions.1 Although the total number of people using the drug has decreased in the past decade, cocaine-related biomedical and psychosocial problems remain a major public health problem in the United States and many other countries. The expanding list of cocaine-related toxic effects, acute and chronic, includes reproductive dysfunction, hepatic necrosis, and pulmonary disease.2 Abuse of and dependence on cocaine may also be associated with disorders of sexual function, sleep, anxiety, and mood, as well as with delirium and psychotic disorders. . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Persistent postwithdrawal disorders have been described with different classes of CNS drugs (e.g.protracted insomnia for alcohol and benzodiazepine withdrawal [10,36] and major depression/dysphoria for cocaine and amphetamine withdrawal [10,23] ), and even more so with specific drugs (e.g.quetiapine and paroxetine) within a drug class [6,15,16,33] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“We now have increasing evidence for postwithdrawal disorders with SSRI long-term use [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Data from controlled trials [15,20,29] , case reports [16] , and online patient reports [26] show that paroxetine is most likely to be associated with new withdrawal symptoms, and fluoxetine the least.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“According to most studies [1,15,16,20,29] , even with gradual tapering, withdrawal symptoms still occur.”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Fava et al. [16] conducted a study of gradual SSRI discontinuation in panic disorder and found that 9 of 20 patients (45%) experienced new withdrawal symptoms, and that 3 of the 9 (33%) patients treated with paroxetine had postwithdrawal disorders at 1 year of follow-up, including bipolar spectrum disorder (n = 2) and major depressive disorder (n = 1).”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“They may resemble rebound symptoms being more severe than the original symptoms, but these disorders persist at least 6 weeks in contrast to rebound symptoms and [6,15,16,26,37] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
In the citing paper
“Persistent postwithdrawal panic disorder [15,38] has been shown to occur following withdrawal of paroxetine, and paroxetine has also been associated with other postwithdrawal disorders [6,15,16] .”
From New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal (2015) · cites this paper as [16]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
An Improved Diagnostic Evaluation Instrument for Substance Abuse Patients
McLellan, A. T., Luborsky, L. B., WOODY, G. E., & Brien, C. P. O. (1980) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198001000-00006 · Cited by 3,163
Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of Cocaine
Ritz, M. C., Lamb, R. J., Goldberg, S. R., & Kuhar, M. J. (1987) · Science · doi:10.1126/science.2820058 · Cited by 2,180
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence
O’Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,476
[Drug addiction and drug abuse].
Feuerlein, W. (1969) · PubMed · Cited by 1,415
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,143
The dopamine hypothesis of the reinforcing properties of cocaine
Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90141-g · Cited by 1,005
Gawin, F. H., & Ellinwood, E. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181806 · Cited by 965
Research works printed but not linked: 22
- Musto DF. The American disease: origins of narcotic control. New Haven, Conn.: Yale University Press, 1973.
- Mendelson JH, Mello NK. Cocaine and other commonly abused drugs. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine. 13th ed. New York: McGraw-Hill, 1994:2429-33.
- National Institute on Drug Abuse. Epidemiologic trends in drug abuse. Vol. 1. Highlights and executive summary. Washington, D.C.: Government Printing Office, 1995. (NIH publication no. 95-3988.)
- Johanson CE, 1989, Pharmacol Rev, 41, 3
- Foltin RW, 1991, J Pharmacol Exp Ther, 257, 247
- McCance EF, 1995, J Pharmacol Exp Ther, 274, 215
- Holman BL, 1991, J Nucl Med, 32, 1206
- Gawin FH, 1988, J Clin Psychiatry, 49, 11
- Millman R, 1988, J Clin Psychiatry, 49, 27
- Mendelson JH, 1992, J Pharmacol Exp Ther, 263, 505
- Mello NK, 1990, J Pharmacol Exp Ther, 254, 815
- Mello NK, 1993, J Pharmacol Exp Ther, 266, 804
- Covi L, 1994, Clin Pharmacol Ther, 55, 132
- Kosten TR, 1987, J Clin Psychiatry, 48, 442
- Kuhar MJ, 1993, Pharmacologist, 35, 28
- Kosten TR, 1988, Am J Psychiatry, 145, 381
- Preston KL, 1993, J Pharmacol Exp Ther, 267, 296
- Kreek MJ. Multiple drug abuse patterns and medical consequences. In: Meltzer HY, ed. Psychopharmacology: the third generation of progress. New York: Raven Press, 1987:1597-604.
- Mendelson JH, Albeck J. Naloxone modification of acute alcohol intoxication in humans. In: Proceedings of the 39th Annual Scientific Meeting, Committee on Problems of Drug Dependence, Cambridge, Mass, July 1977. Washington, D.C.: Committee on Problems of Drug Dependence, 1978:572-82.
- Mendelson JH, 1992, Neuropsychopharmacology, 7, 157
- Gastfriend DR, 1993, Am J Addict, 2, 269
- Gastfriend DR, Mendelson JH, Mello NK, et al. Longitudinal dose comparisons of buprenorphine for combined opiate and cocaine dependence. In: Harris LS, ed. Problems of drug dependence, 1995: proceedings of the 57th Annual Scientific Meeting, the Committee on Problems of Drug Dependence, Inc. NIDA research monograph. Washington, D.C.: Government Printing Office (in press).
Cited by
Sorted by citations
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Arousal and reward: a dichotomy in orexin function
Harris, G. C., & Aston‐Jones, G. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.08.002 · Cited by 567
Management of Drug and Alcohol Withdrawal
Kosten, T. R., & O'Connor, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020617 · Cited by 563
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction
Thomas, M. J., Kalivas, P. W., & Shaham, Y. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.77 · Cited by 521
Camí, J., & Farré, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023160 · Cited by 477
Metadata
- Authors
- Mendelson, J. H., & Mello, N. K.
- Affiliations
- Harvard University (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-04-11
- Volume
- 334
- Issue
- 15
- Pages
- 965-972
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2338649220
- Cited by
- 291
- References
- 112
- Citations by year
- 2024: 4 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 7 · 2014: 9 · 2013: 20 · 2012: 14
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r18da006116-05)
- National Institute on Drug Abuse (DA 06116, K05DA000064, KO5-DA 00101, KO5 DA 00064, K05DA000101)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Youth, Drugs, and Violence
- Keywords
- cocaine abuse, cocaine dependence, cocaine toxicity, reproductive disorders, liver necrosis, lung disease, sexual dysfunction, sleep disorders, anxiety, mood disorders, delirium, psychosis
- MeSH terms
- Antidepressive Agents, Carbamazepine, Cocaine, Humans, Narcotic Antagonists, Narcotics, Dopamine Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
